ATE309817T1 - Pharmazeutische zusammensetzung die trkaig2 enthält zur verwendung in der vorbeugung und/oder behandlung von krebs - Google Patents
Pharmazeutische zusammensetzung die trkaig2 enthält zur verwendung in der vorbeugung und/oder behandlung von krebsInfo
- Publication number
- ATE309817T1 ATE309817T1 AT01956705T AT01956705T ATE309817T1 AT E309817 T1 ATE309817 T1 AT E309817T1 AT 01956705 T AT01956705 T AT 01956705T AT 01956705 T AT01956705 T AT 01956705T AT E309817 T1 ATE309817 T1 AT E309817T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- cancer
- trkaig2
- prevention
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/179—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0020504.7A GB0020504D0 (en) | 2000-08-18 | 2000-08-18 | Therapeutic method |
PCT/GB2001/003682 WO2002015924A1 (en) | 2000-08-18 | 2001-08-17 | Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE309817T1 true ATE309817T1 (de) | 2005-12-15 |
Family
ID=9897960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01956705T ATE309817T1 (de) | 2000-08-18 | 2001-08-17 | Pharmazeutische zusammensetzung die trkaig2 enthält zur verwendung in der vorbeugung und/oder behandlung von krebs |
Country Status (10)
Country | Link |
---|---|
US (2) | US20040037831A1 (de) |
EP (1) | EP1309338B1 (de) |
JP (1) | JP2004506694A (de) |
KR (1) | KR20030040405A (de) |
AT (1) | ATE309817T1 (de) |
AU (2) | AU2001278624B2 (de) |
CA (1) | CA2420051A1 (de) |
DE (1) | DE60115054T2 (de) |
GB (1) | GB0020504D0 (de) |
WO (1) | WO2002015924A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9807781D0 (en) * | 1998-04-09 | 1998-06-10 | Univ Bristol | Therapeutic agent |
US20030096753A1 (en) * | 1998-04-09 | 2003-05-22 | Robertson Alan George Simpson | Therapeutic agent |
GB0020504D0 (en) * | 2000-08-18 | 2000-10-11 | Univ Bristol | Therapeutic method |
GB0122400D0 (en) * | 2001-09-17 | 2001-11-07 | Univ Bristol | Polypeptide purification method |
UA80447C2 (en) | 2002-10-08 | 2007-09-25 | Methods for treating pain by administering nerve growth factor antagonist and opioid analgesic | |
DE60335957D1 (de) | 2002-10-08 | 2011-03-17 | Rinat Neuroscience Corp | Verfahren zur behandlung von postoperativen schmerzen durch verabreichung eines antikörpers gegen nervenwachstumsfaktor und diesen enthaltende zusammensetzungen |
US9498530B2 (en) | 2002-12-24 | 2016-11-22 | Rinat Neuroscience Corp. | Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same |
PT1575517E (pt) | 2002-12-24 | 2012-05-28 | Rinat Neuroscience Corp | Anticorpos anti-ngf e métodos de utilização dos mesmos |
US7569364B2 (en) | 2002-12-24 | 2009-08-04 | Pfizer Inc. | Anti-NGF antibodies and methods using same |
CA2516454A1 (en) | 2003-02-19 | 2004-09-02 | Rinat Neuroscience Corp. | Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same |
KR20060135060A (ko) | 2004-04-07 | 2006-12-28 | 리나트 뉴로사이언스 코퍼레이션 | 신경성장인자 길항제의 투여에 의한 골암 통증의 치료방법 |
WO2007105218A2 (en) * | 2006-03-14 | 2007-09-20 | Yeda Research And Development Co. Ltd. | Composition and method for brain tumor therapy |
EP1857146A1 (de) * | 2006-05-16 | 2007-11-21 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Behandlung von Respiratonsstörungen |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK166763B1 (da) * | 1983-03-16 | 1993-07-12 | Immuno Ag | Immunoglobulin-g-holdig fraktion |
US5789187A (en) * | 1992-08-27 | 1998-08-04 | Worcester Foundation For Experimental Biology | Identification of differentiation factor receptors which inhibit the tumorigenicity of neuroblastoma cells in a ligand-independent manner |
US5844092A (en) * | 1994-03-18 | 1998-12-01 | Genentech, Inc. | Human TRK receptors and neurotrophic factor inhibitors |
US5877016A (en) * | 1994-03-18 | 1999-03-02 | Genentech, Inc. | Human trk receptors and neurotrophic factor inhibitors |
JP2001504349A (ja) * | 1996-11-22 | 2001-04-03 | スージェン・インコーポレーテッド | レセプターチロシンキナーゼ遺伝子 |
US20030096753A1 (en) * | 1998-04-09 | 2003-05-22 | Robertson Alan George Simpson | Therapeutic agent |
GB9807781D0 (en) * | 1998-04-09 | 1998-06-10 | Univ Bristol | Therapeutic agent |
GB0020504D0 (en) * | 2000-08-18 | 2000-10-11 | Univ Bristol | Therapeutic method |
GB0122400D0 (en) * | 2001-09-17 | 2001-11-07 | Univ Bristol | Polypeptide purification method |
-
2000
- 2000-08-18 GB GBGB0020504.7A patent/GB0020504D0/en not_active Ceased
-
2001
- 2001-08-17 AU AU2001278624A patent/AU2001278624B2/en not_active Ceased
- 2001-08-17 WO PCT/GB2001/003682 patent/WO2002015924A1/en active IP Right Grant
- 2001-08-17 US US10/344,856 patent/US20040037831A1/en not_active Abandoned
- 2001-08-17 EP EP01956705A patent/EP1309338B1/de not_active Expired - Lifetime
- 2001-08-17 KR KR10-2003-7002357A patent/KR20030040405A/ko not_active Application Discontinuation
- 2001-08-17 CA CA002420051A patent/CA2420051A1/en not_active Abandoned
- 2001-08-17 DE DE60115054T patent/DE60115054T2/de not_active Expired - Fee Related
- 2001-08-17 JP JP2002520845A patent/JP2004506694A/ja active Pending
- 2001-08-17 AU AU7862401A patent/AU7862401A/xx active Pending
- 2001-08-17 AT AT01956705T patent/ATE309817T1/de not_active IP Right Cessation
-
2006
- 2006-10-13 US US11/580,067 patent/US20070105773A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20070105773A1 (en) | 2007-05-10 |
AU2001278624B2 (en) | 2007-01-18 |
AU7862401A (en) | 2002-03-04 |
DE60115054D1 (de) | 2005-12-22 |
EP1309338A1 (de) | 2003-05-14 |
DE60115054T2 (de) | 2006-07-27 |
EP1309338B1 (de) | 2005-11-16 |
JP2004506694A (ja) | 2004-03-04 |
WO2002015924A1 (en) | 2002-02-28 |
KR20030040405A (ko) | 2003-05-22 |
CA2420051A1 (en) | 2002-02-28 |
GB0020504D0 (en) | 2000-10-11 |
US20040037831A1 (en) | 2004-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0301868A2 (hu) | Gyógyászati készítmény, ami VIIa és XIII-as faktort tartalmaz | |
ATE380548T1 (de) | Verwendung von p53 inhibitoren zur behandlung von nebenerscheinungen bei der krebstherapie | |
JO2373B1 (en) | W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors | |
IS2114B (is) | Kínasólínafleiður til að meðhöndla æxli | |
ATE299022T1 (de) | Verwendung von cyclopamine zur herstellung eines arzneimittels zur behandlung von psoriasis | |
DE60118547D1 (de) | Pharmazeutische zusammensetzung zur behandlung von kolorektalem krebs welche thalidomid und irinotecan enthält | |
ATE265857T1 (de) | Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie | |
HK1075450A1 (en) | heterocyclic compunds, process for their preparation and pharmaceutical compositions containing thenm and thier use in medicine | |
ATE408601T1 (de) | Fredericamycin-derivate | |
ATE309817T1 (de) | Pharmazeutische zusammensetzung die trkaig2 enthält zur verwendung in der vorbeugung und/oder behandlung von krebs | |
DE60136826D1 (de) | Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs | |
PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
ATE219670T1 (de) | Verwendung von arachidonsäure und/oder docohexaensäure zur herstellung eines arzneimittels zur behandlung von dyspraxia | |
DE60233433D1 (de) | PHARMAZEUTISCHE ZUBEREITUNG enthaltend ein Catechin, Ascorbinsäure, Prolin und Lysin ZUR BEHANDLUNG VON NEOPLASTISCHEN KRANKHEITEN | |
ATE308328T1 (de) | Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen | |
DE60203847D1 (de) | Verbindungen enthaltend S-Tofisopam sowie Verwendung dieser Verbindungen zur Herstellung eines Medikamentes zur Behandlung oder Prophylaxe von Krämpfen und Anfällen | |
DE602004016950D1 (de) | Verwendung von cyclin-d1-hemmern zur brustkrebsbehandlung | |
HUP0105281A2 (hu) | Rákellenes hatású benzaldehidszármazékok és gyógyászati alkalmazásuk | |
ATE271861T1 (de) | Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen | |
ATE400277T1 (de) | Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten | |
HUP0401913A2 (hu) | Bromhidrosis kezelésére és megelőzésére szolgáló gyógyszerkészítmény | |
RS60604A (en) | Carboxamidine derivatives and their use in the treatment of vascular diseases | |
ATE382347T1 (de) | Pharmazeutische zusammensetzung zur verwendung bei der behandlung von malignen erkrankungen, umfassend eine kombination aus bisphosphonaten, einem cox-2 inhibitor und einem taxol | |
DE60128009D1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
DE60306503D1 (de) | Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1309338 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |